Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
US FDA Approves New Biktarvy Indication For People With HIV Who Are Treatment Experienced And Restarting Antiretroviral Treatment
Foster City, Calif., July 30, 2025 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Sephience (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the U.S. Food and Drug Administration (FDA) has approved Sephience™...
FDA Approves Skytrofa (lonapegsomatropin-tcgd) for the Once-Weekly Treatment of Adults with Growth Hormone Deficiency
COPENHAGEN, Denmark, July 28, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food &...
FDA Approves Apellis’ Empaveli (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older
Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved Empaveli (pegcetacoplan)...
Increases in Local Violence Tied to Higher Subsequent Suicide Rates
At the county level, increases in homicide rates are linked to higher suicide rates the following year, according to a study published online July...
Cannabis Use Disorder Linked to Increased Risk for Oral Cancer
Cannabis use disorder (CUD) is associated with an increased risk for oral cancer, according to a study published in the September issue of Preventive Medicine...
FDA Approves Empaveli for Rare Kidney Diseases
The U.S. Food and Drug Administration has approved Empaveli (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex...
Preemies' Early-Life Medical Risk Tied to Worse Health at Age 35
Higher early-life medical risk among preterm infants is associated with increased occurrence of mental health disorders, cardiometabolic issues, and body...
New Health Record System Aims to Make Sharing Info Easier, Trump Says
FRIDAY, Aug. 1, 2025 — President Donald Trump has introduced a new effort to help Americans more easily share their health records with doctors,...
Hulk Hogan’s Cause of Death Revealed: Heart Attack at Age 71
FRIDAY, Aug. 1, 2025 — Pro wrestling icon Hulk Hogan died of a heart attack, Florida officials confirmed Thursday. The 71-year-old entertainer,...
Justin Timberlake Reveals Lyme Disease Struggle After Tour
FRIDAY, Aug. 1, 2025 — Singer Justin Timberlake has Lyme disease, a condition he says caused nerve pain, fatigue and other symptoms during his recent...
Deaths to Youths Inhaling 'Laughing Gas' Are Soaring
FRIDAY, Aug. 1, 2025 — It’s no laughing matter: Kids and teens across America are increasingly inhaling nitrous oxide, better known as “laughing...
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated...
Nektar Therapeutics Receives Fast Track Designation for Rezpegaldesleukin for the Treatment of Severe-to-Very Severe Alopecia Areata
Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for...
Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma
SAN DIEGO, July 29, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI),...
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
The U.S. Food and Drug Administration today is taking a bold step to protect Americans from dangerous, illegal opioids by recommending a scheduling action...
Palliative Care or Hospice? What's the Distinction?
SATURDAY, July 26, 2025 — If a doctor diagnoses you with a serious illness and suggests palliative care, don’t jump to conclusions. It doesn’t...
Recently Added
Recently added consumer and prescribing information: Zegfrovy, Lynozyfic, Arynta, Harliku, Ibtrozi, Miudella, Opdivo Qvantig, Alyftrek, Crenessity, Ensacove
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex CareNotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Sephience Sephience (sepiapterin) is a phenylalanine hydroxylase activator used for the treatment of patients with phenylketonuria.
- Anzupgo Anzupgo (delgocitinib) is a topical pan-Janus kinase (JAK) inhibitor for the treatment of chronic hand eczema.
- Kirsty Kirsty (insulin aspart-xjhz) is a rapid acting human insulin analog interchangeable biosimilar to NovoLog (insulin aspart) indicated to...